Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
J Am Soc Nephrol
    May 2024
  1. VELICKOVIC D, Shapiro JP, Parikh SV, Rovin B, et al
    Protein N-glycans in Healthy and Sclerotic Glomeruli in Diabetic Kidney Disease.
    J Am Soc Nephrol. 2024 May 21. doi: 10.1681/ASN.0000000000000393.
    >> Share

  2. DOKE T, Bjornstad P
    Endothelial-Mesenchymal Transition Switch and Diabetic Kidney Disease.
    J Am Soc Nephrol. 2024 May 3. doi: 10.1681/ASN.0000000000000364.
    >> Share

    April 2024
  3. MAXWELL S, Okabe J, Kaipananickal H, Rodriguez H, et al
    Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells.
    J Am Soc Nephrol. 2024 Apr 17. doi: 10.1681/ASN.0000000000000345.
    >> Share

  4. ISAKSSON GL, Hinrichs GR, Andersen H, Bach ML, et al
    Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.
    J Am Soc Nephrol. 2024;35:410-425.
    >> Share

    February 2024
  5. PALMER BF, Clegg DJ
    SGLT2 Inhibition and Tubular Sodium Handling.
    J Am Soc Nephrol. 2024;35:131-133.
    >> Share

  6. CHARU V, Liang JW, Chertow GM, Li J, et al
    Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD.
    J Am Soc Nephrol. 2024;35:216-228.
    >> Share

    January 2024
  7. FWU CW, Eggers PW, Norton JM, Gipson DS, et al
    Age- and Race-Specific Changes in End Stage Kidney Disease Incidence over Four Decades.
    J Am Soc Nephrol. 2024 Jan 30. doi: 10.1681/ASN.0000000000000310.
    >> Share

    December 2023
  8. MAYNE KJ, Staplin N, Keane DF, Wanner C, et al
    Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease.
    J Am Soc Nephrol. 2023 Dec 12. doi: 10.1681/ASN.0000000000000271.
    >> Share

  9. PERICO N, Griffin MD, Casiraghi F, Remuzzi G, et al
    Authors' Reply: Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?
    J Am Soc Nephrol. 2023;34:2052-2053.
    >> Share

  10. CHEN JZ, Liang B
    Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?
    J Am Soc Nephrol. 2023;34:2051-2052.
    >> Share

  11. FLETCHER RA, Jongs N, Chertow GM, McMurray JJV, et al
    Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials.
    J Am Soc Nephrol. 2023;34:1965-1975.
    >> Share

    November 2023
  12. ZHOU J, Abedini A, Balzer MS, Shrestha R, et al
    Unified Mouse and Human Kidney Single-Cell Expression Atlas Reveal Commonalities and Differences in Disease States.
    J Am Soc Nephrol. 2023;34:1843-1862.
    >> Share

    September 2023
  13. SALEMKOUR Y, Yildiz D, Dionet L, T Hart DC, et al
    Podocyte Injury in Diabetic Kidney Disease in a Mouse Model Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
    J Am Soc Nephrol. 2023 Sep 6. doi: 10.1681/ASN.0000000000000212.
    >> Share

    August 2023
  14. PERICO N, Remuzzi G, Griffin MD, Cockwell P, et al
    Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M Cell) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
    J Am Soc Nephrol. 2023 Aug 10. doi: 10.1681/ASN.0000000000000189.
    >> Share

  15. MURPHY DP, Wolfson J, Reule S, Johansen KL, et al
    Renin-Angiotensin-Aldosterone System Blockade after Acute Kidney Injury with or without Recovery among US Veterans with Diabetic Kidney Disease.
    J Am Soc Nephrol. 2023 Aug 7. doi: 10.1681/ASN.0000000000000196.
    >> Share

    July 2023
  16. ZHU Z, Rosenkranz KA, Kusunoki Y, Li C, et al
    Finerenone Added to RAS/SGLT2 Blockade for Chronic Kidney Disease in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice.
    J Am Soc Nephrol. 2023 Jul 10. doi: 10.1681/ASN.0000000000000186.
    >> Share

  17. HIROHAMA D, Abedini A, Moon S, Surapaneni A, et al
    Unbiased Human Kidney Tissue Proteomics Identifies Matrix Metalloproteinase 7 as a Kidney Disease Biomarker.
    J Am Soc Nephrol. 2023;34:1279-1291.
    >> Share

  18. FU EL, Levey AS, Coresh J, Elinder CG, et al
    Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations.
    J Am Soc Nephrol. 2023;34:1241-1251.
    >> Share

  19. KUCHARCZYK P, Albano G, Deisl C, Ho TM, et al
    Thiazides Attenuate Insulin Secretion Through Inhibition of Mitochondrial Carbonic Anhydrase 5b in beta -Islet Cells in Mice.
    J Am Soc Nephrol. 2023;34:1179-1190.
    >> Share

    June 2023
  20. PACKER M
    Fetal Reprogramming of Nutrient Surplus Signaling, O-GlcNAcylation, and the Evolution of Chronic Kidney Disease.
    J Am Soc Nephrol. 2023 Jun 21. doi: 10.1681/ASN.0000000000000177.
    >> Share

    May 2023
  21. HASEGAWA K, Sakamaki Y, Tamaki M, Wakino S, et al
    PCK1 Protects Against Mitoribosomal Defects in Diabetic Nephropathy in Mouse Models.
    J Am Soc Nephrol. 2023 May 18. doi: 10.1681/ASN.0000000000000156.
    >> Share

    April 2023
  22. CHANDRA M, Hertel M, Cahill S, Sakaguchi K, et al
    Prevalence of Self-Reported Kidney Disease in Older Adults by Sexual Orientation: Behavioral Risk Factor Surveillance System Analysis (2014-2019).
    J Am Soc Nephrol. 2023;34:682-693.
    >> Share

    February 2023
  23. REFARDT J, Imber C, Nobbenhuis R, Sailer CO, et al
    Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    J Am Soc Nephrol. 2023;34:322-332.
    >> Share

    January 2023
  24. CHOI S, Hong SP, Bae JH, Suh SH, et al
    Hyperactivation of YAP/TAZ Drives Alterations in Mesangial Cells through Stabilization of N-Myc in Diabetic Nephropathy.
    J Am Soc Nephrol. 2023 Jan 21. doi: 10.1681/ASN.0000000000000075.
    >> Share

    December 2022
  25. CREWS DC, Patzer RE, Cervantes L, Knight R, et al
    Designing Interventions Addressing Structural Racism to Reduce Kidney Health Disparities: A Report from a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
    J Am Soc Nephrol. 2022;33:2141-2152.
    >> Share

  26. MITROFANOVA A, Fontanella A, Tolerico M, Mallela S, et al
    Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases.
    J Am Soc Nephrol. 2022;33:2153-2173.
    >> Share

    October 2022
  27. REAVES AC, Levey AS
    Sex Disparities in the Quality of Care for CKD.
    J Am Soc Nephrol. 2022;33:1804-1806.
    >> Share

    August 2022
  28. JONGS N, Chertow G, Greene T, McMurray J, et al
    Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Aug 17. pii: ASN.2022030306. doi: 10.1681/ASN.2022030306.
    >> Share

    June 2022
  29. YUN HR, Joo YS, Kim HW, Park JT, et al
    Coronary Artery Calcification Score and the Progression of Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2022010080. doi: 10.1681/ASN.2022010080.
    >> Share

  30. FARRE R, Dejongh S, Meijers B
    Of Mice and MAVS-Diabetic Kidney Disease and the Leaky Gut.
    J Am Soc Nephrol. 2022;33:1053-1055.
    >> Share

  31. HARMACEK D, Pruijm M, Burnier M, Muller ME, et al
    Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate.
    J Am Soc Nephrol. 2022;33:1073-1075.
    >> Share

    May 2022
  32. CHEN TK, Coca SG, Estrella MM, Appel LJ, et al
    Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-D.
    J Am Soc Nephrol. 2022;33:996-1010.
    >> Share

    March 2022
  33. FINCH N, Fawaz S, Neal C, Butler M, et al
    Reduced Glomerular Filtration in Diabetes is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell Fenestrations.
    J Am Soc Nephrol. 2022 Mar 15. pii: ASN.2021030294. doi: 10.1681/ASN.2021030294.
    >> Share

  34. LINH H, Iwata Y, Senda Y, Sakai-Takemori Y, et al
    Intestinal Bacterial Translocation Contributes to Diabetic Kidney Disease.
    J Am Soc Nephrol. 2022 Mar 9. pii: ASN.2021060843. doi: 10.1681/ASN.2021060843.
    >> Share

    January 2022
  35. AGARWAL R, Joseph A, Anker SD, Filippatos G, et al
    Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.
    J Am Soc Nephrol. 2022;33:225-237.
    >> Share

    December 2021
  36. SHAHZAD K, Fatima S, Al-Dabet MM, Gadi I, et al
    CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease.
    J Am Soc Nephrol. 2021;32:3066-3079.
    >> Share

    November 2021
  37. IBRAHIM HN, Murad DN, Hebert SA, Adrogue HE, et al
    Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors.
    J Am Soc Nephrol. 2021;32:2933-2947.
    >> Share

  38. HEERSPINK HJL, Xie D, Bakris G, Correa-Rotter R, et al
    Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial.
    J Am Soc Nephrol. 2021;32:2900-2911.
    >> Share

  39. GOVIND D, Becker JU, Miecznikowski J, Rosenberg AZ, et al
    PodoSighter: A Cloud-Based Tool for Label-Free Podocyte Detection in Kidney Whole-Slide Images.
    J Am Soc Nephrol. 2021;32:2795-2813.
    >> Share

    October 2021

  40. Correction: Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.
    J Am Soc Nephrol. 2021;32:2683.
    >> Share

  41. LIU L, Kiryluk K
    Coding Variants in Susceptibility to Diabetic Kidney Disease.
    J Am Soc Nephrol. 2021;32:2397-2399.
    >> Share

    July 2021
  42. CHERTOW G, Vart P, Jongs N, Toto R, et al
    Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Jul 16. pii: ASN.2021020167. doi: 10.1681/ASN.2021020167.
    >> Share

    June 2021
  43. THORSNESS R, Swaminathan S, Lee Y, Sommers BD, et al
    Medicaid Expansion and Incidence of Kidney Failure among Nonelderly Adults.
    J Am Soc Nephrol. 2021;32:1425-1435.
    >> Share

    May 2021
  44. VEIRAS LC, Shen JZY, Bernstein EA, Regis GC, et al
    Renal Inflammation Induces Salt Sensitivity in Male db/db Mice through Dysregulation of ENaC.
    J Am Soc Nephrol. 2021;32:1131-1149.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016